BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 8156095)

  • 1. Early postoperative evaluation in patients with Cushing's disease: usefulness of ovine corticotropin-releasing hormone test in the prediction of recurrence of disease.
    Vignati F; Berselli ME; Loi P
    Eur J Endocrinol; 1994 Mar; 130(3):235-41. PubMed ID: 8156095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome.
    Avgerinos PC; Chrousos GP; Nieman LK; Oldfield EH; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1987 Nov; 65(5):906-13. PubMed ID: 3499448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Undetectable postoperative cortisol does not always predict long-term remission in Cushing's disease: a single centre audit.
    Yap LB; Turner HE; Adams CB; Wass JA
    Clin Endocrinol (Oxf); 2002 Jan; 56(1):25-31. PubMed ID: 11849243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postoperative plasma cortisol levels predict long-term outcome in patients with Cushing's disease and determine which patients should be treated with pituitary irradiation after surgery.
    Imaki T; Tsushima T; Hizuka N; Odagiri E; Murata Y; Suda T; Takano K
    Endocr J; 2001 Feb; 48(1):53-62. PubMed ID: 11403103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing's disease.
    Colombo P; Dall'Asta C; Barbetta L; Re T; Passini E; Faglia G; Ambrosi B
    Eur J Endocrinol; 2000 Aug; 143(2):227-34. PubMed ID: 10913942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term remission rates after pituitary surgery for Cushing's disease: the need for long-term surveillance.
    Atkinson AB; Kennedy A; Wiggam MI; McCance DR; Sheridan B
    Clin Endocrinol (Oxf); 2005 Nov; 63(5):549-59. PubMed ID: 16268808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI; Lin SY; Won JG; Tang KT; Jap TS; Kwok CF; Lin HD
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct; 65(10):474-82. PubMed ID: 12523812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease.
    Nieman LK; Cutler GB; Oldfield EH; Loriaux DL; Chrousos GP
    J Clin Endocrinol Metab; 1989 Jul; 69(1):165-9. PubMed ID: 2543689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The corticotropin-releasing hormone test in the diagnosis of ACTH-dependent Cushing's syndrome: a reappraisal.
    Pecori Giraldi F; Invitti C; Cavagnini F;
    Clin Endocrinol (Oxf); 2001 May; 54(5):601-7. PubMed ID: 11380490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin releasing hormone stimulation test: diagnostic aspects in Cushing's syndrome.
    Boscaro M; Rampazzo A; Sonino N; Merola G; Scanarini M; Mantero F
    J Endocrinol Invest; 1987 Jun; 10(3):297-302. PubMed ID: 3040851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome.
    Chrousos GP; Schulte HM; Oldfield EH; Gold PW; Cutler GB; Loriaux DL
    N Engl J Med; 1984 Mar; 310(10):622-6. PubMed ID: 6319991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticotropin-releasing hormone stimulation test before and after transsphenoidal selective microadenomectomy in 30 patients with Cushing's disease.
    Schrell U; Fahlbusch R; Buchfelder M; Riedl S; Stalla GK; Müller OA
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1150-9. PubMed ID: 3033006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of the corticotropin-releasing hormone test to monitor the recovery of patients with Cushing's disease or Cushing's syndrome due to an adrenal adenoma after adenomectomy.
    Hotta MN; Shibasaki T; Suda T; Ling N; Shizume K
    Endocrinol Jpn; 1985 Feb; 32(1):113-25. PubMed ID: 2990881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone and prolactin responses to corticotrophin-releasing-hormone in patients with Cushing's disease: a paracrine action of the adenomatous corticotrophic cells?
    Loli P; Boccardi E; Branca V; Bramerio M; Barberis M; Losa M; Terreni MT; Lodrini S; Pollo B; Vignati F
    Clin Endocrinol (Oxf); 1998 Oct; 49(4):433-9. PubMed ID: 9876339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative metyrapone test in the early assessment of outcome of pituitary surgery for Cushing's disease.
    van Aken MO; de Herder WW; van der Lely AJ; de Jong FH; Lamberts SW
    Clin Endocrinol (Oxf); 1997 Aug; 47(2):145-9. PubMed ID: 9302385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome.
    Findling JW; Kehoe ME; Shaker JL; Raff H
    J Clin Endocrinol Metab; 1991 Aug; 73(2):408-13. PubMed ID: 1649842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of postoperative ACTH levels as a marker for successful transsphenoidal microsurgery in Cushing's disease.
    Flitsch J; Knappe UJ; Lüdecke DK
    Zentralbl Neurochir; 2003; 64(1):6-11. PubMed ID: 12582940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of pituitary-adrenal axis to corticotrophin releasing hormone in patients with Cushing's disease before and after ketoconazole treatment.
    Boscaro M; Sonino N; Rampazzo A; Mantero F
    Clin Endocrinol (Oxf); 1987 Oct; 27(4):461-7. PubMed ID: 2830063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Responsivity of adrenocorticotropin to corticotropin-releasing hormone and lack of suppressibility by dexamethasone are related phenomena in Cushing's disease.
    Hermus AR; Pieters GF; Pesman GJ; Smals AG; Benraad TJ; Kloppenborg PW
    J Clin Endocrinol Metab; 1986 Apr; 62(4):634-9. PubMed ID: 3005353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.